TODAY : Monday, 21 April 2025
Code
IKPM
Title
PT Ikapharmindo Putramas Tbk
Address
Head Office:
Address:Jl. Pulogadung Raya No.29 Kawasan Industri Pulogadung
Jakarta Timur 13930 Indonesia
Phone:(021) 460 0086
Fax:(021) 460 8865
E-mail:[email protected]
Website:www.ikapharmindo.com
Factory Location:
Jl. Raya Rancaekek KM.24 Kav. 5 BB RT02/RW07 Kawasan Industri Dwipapuri Abadi,
Desa Sawah Dadap, Kec. Cimanggung, Sumedang 40394 Jawa Barat
Phone:-
Fax:-
E-mail:[email protected]
Website:www.ikapharmindo.com
Background

Business of The Company is pharmaceutical and personal care industry.

Business cp product

Business of The Company is pharmaceutical and personal care industry.

Subsidiary affiliation
SubsidiariesDomicileBusiness
PT Distriversa BuanamasJakartaPharmaceutical wholesaler97.5
Commissioners
President Commissioner: Maudy Ratna Winata
Commissioner: Titianus Winata
Independent Commissioner: Susanto Lam
Per 27 Jun 2023
Directors
President Director: Kartono
Director: Ayi Saepudin
Director: Eliza Arlena Winata
Per 27 Jun 2023
Underwriter
PT. OCBC Sekuritas
Share registrar
Share holders
ShareholdersShares
PT Ikapharma Inti Mas131595000078.12
Dra. Maudy Ratna Winata148400000.88
Drs. Titianus Winata104600000.62
Augustina Winata32400000.19
Eliza Arlena Winata32400000.19
Public33693250020
As of Apr 30, 2023
History stocks

Type of ListingDatePrice## of SharesTotal Listed Shares

IPO @ Rp. 16508-Nov-20231003369325001684662500

Other infos

Employee Stock Allocation/ESA 100,000 Shares

Created date
2023-11-06 15:37:53
Revised date
2023-11-06 15:39:12
Finance
 
PT Ikapharmindo Putramas Tbk
 
Financial Statetment Date
Fiscal Year Ends
Months Covered in Income St
 
Summary Covered in Income St
Cash and Cash Equivalents
Receivables
Inventories
Current Assets
Fixed Assets
Other Assets
Non Current Assets
Total Assets
Current Liabilities
Longterm Liabilities
Total Liabilities
Authorized
Paid-up Capital
Par Value
Paid-up Capital Shares
Retained Earnings
Total Equity
Minority Interest
 
Summary of Income Statement
Total Sales
Cost of Good Sold
Gross Profit
Operating Profit
Other Income
Earning Before Tax
Tax
Net Income
Close Price
 
Per Share Data (Rp)
Eps (annualized)
Book Value
 
Financial Ratios
Debt Equity Ratio (X)
Roa(%)
Roe(%)
Npm(%)
Opm(%)
Gross Profit Margin (%)
Total Assets Turnover
 
Cash Flow
CF from Operation Activities
CF from Investing Activities
CF from Financing Activities
Net Increase in Cash & Cash Equivalent
Cash & Cash Equivalent at Beginning of the Year
Cash & Cash Equivalent at The End of the Year
2021-12-31
Dec
12
 
 
1,430,873,501.00
15,354,691,075.00
5,375,861,327.00
22,750,784,719.00
8,229,621,515.00
19,572,880.00
15,754,551,549.00
38,505,336,268.00
17,326,084,005.00
1,607,678,109.00
18,933,762,114.00
25,000.00
10,000,000,000.00
100,000.00
10,000.00
8,283,164,492.00
19,571,574,154.00
0.00
 
 
38,091,739,652.00
20,276,421,428.00
17,815,318,224.00
2,257,367,204.00
-1,046,252,389.00
1,211,114,815.00
398,584,934.00
812,529,881.00
0.00
 
 
8,125,299.00
195,715,742.00
 
 
97.00
211.00
415.00
213.00
593.00
4,677.00
99.00
 
 
7,846,307,132.00
-141,972,136.00
-7,004,688,114.00
699,646,882.00
2,082,285,621.00
1,430,873,501.00